Demand for Yeast Infection Treatment in Japan

Future Market Insights

Key Insight

The demand for yeast infection treatment in Japan is projected to grow from USD 315.5 million in 2025 to USD 455.8 million by 2035, at a CAGR of 3.8%. Azoles will dominate with a 42.1% market share, while genital candidiasis will lead the indication segment with a 38.5% share.

November 26, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Yeast Infection Treatment in Japan

https://www.futuremarketinsights.com/reports/japan-yeast-infection-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Bayer Yakuhin
Hisamitsu Pharmaceutical Co
Kowa Company Ltd
Sato Pharmaceutical Co. Ltd
Taisho Pharmaceutical Holdings Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Yeast Infection Treatment in Japan

Key Players

Similar Industry Reports